Potassium Phosphate, Tribasic → HCID 89524899, compound
Reaction equation
CC1(C)C2C(=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=CC=2)OC2C(P(C3C=CC=CC=3)C3C=CC=CC=3)=CC=CC1=2.CC1(C)C(C)(C)OB([C:51]2[CH:65]=[CH:64][CH:63]=[CH:62][C:52]=2[CH2:53][NH:54][C:55](=[O:61])[O:56][C:57]([CH3:60])([CH3:59])[CH3:58])O1.[I:67][C:68]1[O:69][CH:70]=[C:71](I)[N:72]=1.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[I:67][C:68]1[O:69][CH:70]=[C:71]([C:51]2[CH:65]=[CH:64][CH:63]=[CH:62][C:52]=2[CH2:53][NH:54][C:55](=[O:61])[O:56][C:57]([CH3:58])([CH3:59])[CH3:60])[N:72]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Palladium(II) acetate (35.0 mg, 0.156 mmol) and Xantphos (90 mg, 0.156 mmol) was added to degassed THF (3 ml) and let stir for 5 minutes then transferred to a separate rxn vessel that contained tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzylcarbamate (1142 mg, 3.43 mmol), 2,4-diiodooxazole (1000 mg, 3.12 mmol), Potassium phosphate (1985 mg, 9.35 mmol) and degassed Tetrahydrofuran (THF) (12 mL). The rxn vessel was capped and heated to 80° for 16 hours. Filtered and the residue was purified via Biotage (0% to 100% DCM:Hex; 50 g-HP-silica gel column) to obtain 460 mg of tert-butyl 2-(2-iodooxazol-4-yl)benzylcarbamate. 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.47 (s, 9H) 4.39 (d, J=5.31 Hz, 2H) 5.40 (br. s., 1H) 7.31-7.45 (m, 2H) 7.53 (dd, J=19.45, 7.07 Hz, 2H) 7.94 (s, 1H); MS[MH]+=401.1
Workup
- customto degassed THF (3 ml)
- customthen transferred to a separate rxn vessel
- customdegassed Tetrahydrofuran (THF) (12 mL)
- customThe rxn vessel was capped
- temperatureheated to 80° for 16 hours
- filtrationFiltered
- customthe residue was purified via Biotage (0% to 100% DCM:Hex; 50 g-HP-silica gel column)
Sources & evidence
- ORD record
- ord-bec631d9396a48a1883eb06d86e8d5c1
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09174984B2
Reaction notes
Loading…